[go: up one dir, main page]

UY27049A1 - PHARMACEUTICAL COMPOSITIONS - Google Patents

PHARMACEUTICAL COMPOSITIONS

Info

Publication number
UY27049A1
UY27049A1 UY27049A UY27049A UY27049A1 UY 27049 A1 UY27049 A1 UY 27049A1 UY 27049 A UY27049 A UY 27049A UY 27049 A UY27049 A UY 27049A UY 27049 A1 UY27049 A1 UY 27049A1
Authority
UY
Uruguay
Prior art keywords
pharmaceutical compositions
oenic
dihydroxyhep
methylsulfonyl
pyrimidin
Prior art date
Application number
UY27049A
Other languages
Spanish (es)
Inventor
Creekmore Joseph Richard
Wiggins Norman Alfred
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to UY27049A priority Critical patent/UY27049A1/en
Publication of UY27049A1 publication Critical patent/UY27049A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención se refiere a una composición farmacéutica que contiene el inhibidor de reductasa HMG CoA ácido (E)-7-(4-(4-fluorofenil)-6-isopropil-2-(metil(metilsulfonil)amino) pirimidin-5-il)-(3R,5S)-3,5-dihidroxihep-6-enóico o una sal farmacéuticamente aceptable del mismo como ingrediente activo, que permanece estable durante un de tiempo prolongado.The invention relates to a pharmaceutical composition containing the HMG CoA reductase inhibitor (E) -7- (4- (4-fluorophenyl) -6-isopropyl-2- (methyl (methylsulfonyl) amino) pyrimidin-5-yl ) - (3R, 5S) -3,5-dihydroxyhep-6-oenic or a pharmaceutically acceptable salt thereof as an active ingredient, which remains stable for a long time.

UY27049A 2001-11-30 2001-11-30 PHARMACEUTICAL COMPOSITIONS UY27049A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY27049A UY27049A1 (en) 2001-11-30 2001-11-30 PHARMACEUTICAL COMPOSITIONS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY27049A UY27049A1 (en) 2001-11-30 2001-11-30 PHARMACEUTICAL COMPOSITIONS

Publications (1)

Publication Number Publication Date
UY27049A1 true UY27049A1 (en) 2002-03-22

Family

ID=38812539

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27049A UY27049A1 (en) 2001-11-30 2001-11-30 PHARMACEUTICAL COMPOSITIONS

Country Status (1)

Country Link
UY (1) UY27049A1 (en)

Similar Documents

Publication Publication Date Title
AR023624A1 (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE AN HMG COA REDUCTASA INHIBITOR
CY1109756T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING Crystalline Salts 7- [4- (4-Fluorophenyl) -6-Isopropyl-2- [Methyl (Methylsulfonyl) -5-5-yl] -3-5-amino-3-yl] -5-y -NIGHT ACID
AR031766A1 (en) THERAPY
CY1113395T1 (en) STABLE PHARMACEUTICAL COMPOSITION CONTAINING PYRIMIDINE-SULFAMIDI
EA200702198A1 (en) PHARMACEUTICAL COMPOSITIONS
CO5590918A2 (en) FORMULATIONS
RS51923B (en) Salt of [[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyI]amino]-2-, Pyrimidinyl]amino]benzonitrile
WO2010030201A3 (en) Stable oral pharmaceutical composition containing a pharmaceutically acceptable salt of [(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonyl)amino]pyrimidine-5-yl] (3r, 5s) - 3,5 dihydroxyhept-6- enoic acid
UY27049A1 (en) PHARMACEUTICAL COMPOSITIONS
CR9032A (en) 4 - ((4 - ((4- (2-CYANETHETHYL)) -2,6-DIMETHYLPHENYL) AMINO-2- PYRIMIDINYL) AMINO) BENZONITRILE FUMARATE
UY27271A1 (en) PHARMACEUTICAL COMPOSITIONS
UY30336A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ACID (E) -7- (4- (4-FLUOROPHENYL) -6-ISOPROPIL-2- (METHYL (METILSULFONIL) AMINO) PIRIMIDIN-5-IL) - (3R, 5S) -3,5-DIHYDROXIHEPT -6-ENOICO AND PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME
EP1757593A4 (en) THERAPEUTIC AGENT FOR NON-VIRAL HEPATITIS
HRP20110563T1 (en) Salt of 4[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
UY28575A1 (en) SOLID PHARMACEUTICAL COMPOSITIONS INCLUDING ACID BIS (E) -7- (4- (4-FLUORPHENYL-6-ISOPROPIL-2- (METHYL (METILSULFONYL) AMINO) PIRIMIDIN- 5-IL) -3R, 5S) -3.5 - DIHYDROXO- ............

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20161025